Swedish firm partners with Sanofi to expand in Asia

Singapore: Sweden-based company NeuroVive Pharmaceutical's Asia arm has signed a collaboration agreement with Sanofi's a...

May 27, 2015 | Wednesday | News
WuXi CRO gets toxicity prediction software license

Singapore: WuXi PharmaTech, a China-based contract research organization (CRO), has obtained a multiyear license to Adme...

November 13, 2013 | Wednesday | News
Asthma therapy market to touch $23.1 bn by 2023

Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countr...

September 8, 2014 | Monday | Analysis
Nemus' glaucoma drug secures patent in Japan

Nemus Bioscience Inc. has announced that the pro-drug of tetrahydrocannabinol (THC) in-licensed from the company's resea...

October 26, 2015 | Monday | News
Israel firm to develop epilepsy drug in China

Singapore: Chinese Food and Drug Administration (CFDA) has approved Israel based D-Pharm to conduct clinical development...

April 15, 2015 | Wednesday | News
UK pours $500 mn in genome sequencing

Singapore:  In a move to accelerate genome sequencing and bring breakthrough in cancer treatment in the country, UK h...

August 1, 2014 | Friday | News
Mochida seeks Ulcerative Colitis drug approval in Japan

Tokyo's Mochida Pharmaceutical Co. Ltd. has filed for a new drug application (NDA) for MD-0901 with the Japanese Ministr...

November 6, 2015 | Friday | News
Sanofi terminates NaP2b inhibitors development deal with Ardelyx

Singapore: Sanofi has terminated NaP2b inhibitors development deal with US based Ardelyx, a clinical-stage biopharmaceut...

September 3, 2015 | Thursday | News
AB SCIEX, Dalton Pharma to advance antibody drug conjugate analysis

Singapore: Global technology firm AB SCIEX and Dalton Pharma Services have formed a research collaboration to develop An...

August 27, 2014 | Wednesday | News
Profits - A stumbling block for Ebola research

Singapore: Global experts have commented that the lack of adequate funding was a major drawback that discouraged researc...

September 16, 2014 | Tuesday | News
Aussie firm to initiate oncology clinical trial in Europe

Singapore: Australia based drug discovery company, Viralytics, has recieved UK Medicines and Healthcare Products Regulat...

November 14, 2014 | Friday | News
AMRI receives NIH contract for clinical drug product

Singapore: Clinical research firm, AMRI, has received a 10-year federal contract award from the National Institutes of H...

January 23, 2015 | Friday | News
Singapore start-up progresses in Alzheimer's drug

Singapore: Singapore start-up and Scotland based TauRx Therapeutics is progressing in its two Phase III clinical trials ...

September 22, 2014 | Monday | News
Novartis: Lucentis reduces AMD blindness by 50%

Singapore: Novartis revealed new clinical data associated with the eye drug Lucentis (ranibizumab) admist a total of 209...

May 8, 2013 | Wednesday | News
Genovate, ScinoPharm co-develop Hep B Drug

Singapore: Taiwan based Genovate Biotechnology and ScinoPharm have jointly developed the highly potent oral generic drug...

November 14, 2013 | Thursday | News
Roche acquires respiratory therapy firm at $8.3 bn

Singapore: Global biopharmaceutical company, Roche, has acquired InterMune, a biotechnology company focused on the resea...

August 27, 2014 | Wednesday | News
Neurocrine Biosciences collaborates with Mitsubishi Tanabe Pharma

Nasdaq-listed Neurocrine Biosciences has entered into an exclusive collaboration and licensing agreement for the develop...

April 5, 2015 | Sunday | News
Daiichi Sankyo initiates TaNeDS drug discovery program in Europe

Tokyo: Japan's Daiichi Sankyo Company Limited has announced details of the application for its Take a New Challenge for ...

October 1, 2015 | Thursday | News
Aussie firm gets FDA green flag for oncology drug

Singapore: Australia biotech firm, Prescient Therapeutics, a clinical stage oncology company, has secured agreement from...

April 2, 2015 | Thursday | Regulatory
Pomalidomide Celgene gets EU nod for multiple myeloma

Singapore: European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing a...

June 4, 2013 | Tuesday | Regulatory
Spinifex capitalizes on pain management market

Realizing the need for improved therapies in the highly unmet field of pain management, Australia-based Spinifex has bee...

March 14, 2012 | Wednesday | News
Gilead's Viread patent revoked in China

Singapore: China's State Intellectual Property Office (SIPO) has yanked the patent for Gilead Sciences popular HIV and h...

August 8, 2013 | Thursday | News
Companion diagnostic drug for prostate cancer from Japan

Singapore: Japan's Tokai Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel therapi...

March 17, 2015 | Tuesday | News
Biogen, Elan drug effective for multiple sclerosis

Singapore: A study conducted on Biogen and Elan Pharmaceuticals's natalizumab has been shown to be effective for treatin...

March 11, 2013 | Monday | News
Roche, AstraZeneca form firm to share R&D data

Singapore: Roche and AstraZeneca entered into a collaboration to share early research data generated by Matched Molecula...

June 27, 2013 | Thursday | News